The Board of Directors of GlaxoSmithKline Pharmaceuticals Limited at its meeting held yesterday approved the sale of the Company’s business undertaking i.e., manufacturing facility together with the land, plant and machinery, assets, software and equipment located at Vemgal, Karnataka to Hetero Labs Limited.
The Transaction is subject to receipt of all statutory approvals from the concerned authorities & members of the Company and signing of the definitive documents between the Company and Hetero Labs Limited in this regard.
